| Amy Susan Kranick, CNM | |
|
140 Hospital Dr, Suite 306, Bennington, VT 05201-5009 | |
| (802) 447-2677 | |
| (802) 447-7710 |
| Full Name | Amy Susan Kranick |
|---|---|
| Gender | Female |
| Speciality | Certified Nurse Midwife (cnm) |
| Experience | 27 Years |
| Location | 140 Hospital Dr, Bennington, Vermont |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114037231 | NPI | - | NPPES |
| 1010650 | Medicaid | VT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 101-0025239 (Vermont) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southwestern Vermont Medical Center | Bennington, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southwestern Vermont Medical Center Inc | 0143138446 | 142 |
News Archive
Onyx Pharmaceuticals, Inc. today announced that it has reached the target enrollment in the ASPIRE trial, a Phase 3 international clinical trial evaluating carfilzomib in combination with lenalidomide (Revlimid) and low dose dexamethasone in patients with relapsed multiple myeloma.
Click4Care, a leading provider of care management software for payors, today announced the next-generation Utilization Management (UM) module for its industry leading software platform. By leveraging the UM solution's extensive configurability, payors and providers can achieve greater levels of productivity while improving clinical, administrative and financial performances.
There are a number of simple, practical steps that families can take-;including reducing passive screen time and news consumption, having a structured daily schedule and getting enough sleep-;that can promote resilience against mental health problems in youth during the COVID-19 pandemic, according to a new study published this week in the open-access journal PLOS ONE by Maya Rosen of Harvard University, US, and colleagues.
A new study found that treatment-resistant epilepsy (TRE) is common in idiopathic autism. Early age at the onset of seizures and delayed global development were associated with a higher frequency of resistance to antiepileptic drugs (AEDs). Full findings appear online in Epilepsia, a journal published by Wiley-Blackwell on behalf of the International League Against Epilepsy (ILAE).
› Verified 1 days ago
| Entity Name | Southwestern Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205865789 PECOS PAC ID: 0143138446 Enrollment ID: O20060929000045 |
News Archive
Onyx Pharmaceuticals, Inc. today announced that it has reached the target enrollment in the ASPIRE trial, a Phase 3 international clinical trial evaluating carfilzomib in combination with lenalidomide (Revlimid) and low dose dexamethasone in patients with relapsed multiple myeloma.
Click4Care, a leading provider of care management software for payors, today announced the next-generation Utilization Management (UM) module for its industry leading software platform. By leveraging the UM solution's extensive configurability, payors and providers can achieve greater levels of productivity while improving clinical, administrative and financial performances.
There are a number of simple, practical steps that families can take-;including reducing passive screen time and news consumption, having a structured daily schedule and getting enough sleep-;that can promote resilience against mental health problems in youth during the COVID-19 pandemic, according to a new study published this week in the open-access journal PLOS ONE by Maya Rosen of Harvard University, US, and colleagues.
A new study found that treatment-resistant epilepsy (TRE) is common in idiopathic autism. Early age at the onset of seizures and delayed global development were associated with a higher frequency of resistance to antiepileptic drugs (AEDs). Full findings appear online in Epilepsia, a journal published by Wiley-Blackwell on behalf of the International League Against Epilepsy (ILAE).
› Verified 1 days ago
| Entity Name | Women's View Midwifery |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730286956 PECOS PAC ID: 6800892894 Enrollment ID: O20061016000092 |
News Archive
Onyx Pharmaceuticals, Inc. today announced that it has reached the target enrollment in the ASPIRE trial, a Phase 3 international clinical trial evaluating carfilzomib in combination with lenalidomide (Revlimid) and low dose dexamethasone in patients with relapsed multiple myeloma.
Click4Care, a leading provider of care management software for payors, today announced the next-generation Utilization Management (UM) module for its industry leading software platform. By leveraging the UM solution's extensive configurability, payors and providers can achieve greater levels of productivity while improving clinical, administrative and financial performances.
There are a number of simple, practical steps that families can take-;including reducing passive screen time and news consumption, having a structured daily schedule and getting enough sleep-;that can promote resilience against mental health problems in youth during the COVID-19 pandemic, according to a new study published this week in the open-access journal PLOS ONE by Maya Rosen of Harvard University, US, and colleagues.
A new study found that treatment-resistant epilepsy (TRE) is common in idiopathic autism. Early age at the onset of seizures and delayed global development were associated with a higher frequency of resistance to antiepileptic drugs (AEDs). Full findings appear online in Epilepsia, a journal published by Wiley-Blackwell on behalf of the International League Against Epilepsy (ILAE).
› Verified 1 days ago
| Entity Name | Southwestern Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184994162 PECOS PAC ID: 0143138446 Enrollment ID: O20120613000217 |
News Archive
Onyx Pharmaceuticals, Inc. today announced that it has reached the target enrollment in the ASPIRE trial, a Phase 3 international clinical trial evaluating carfilzomib in combination with lenalidomide (Revlimid) and low dose dexamethasone in patients with relapsed multiple myeloma.
Click4Care, a leading provider of care management software for payors, today announced the next-generation Utilization Management (UM) module for its industry leading software platform. By leveraging the UM solution's extensive configurability, payors and providers can achieve greater levels of productivity while improving clinical, administrative and financial performances.
There are a number of simple, practical steps that families can take-;including reducing passive screen time and news consumption, having a structured daily schedule and getting enough sleep-;that can promote resilience against mental health problems in youth during the COVID-19 pandemic, according to a new study published this week in the open-access journal PLOS ONE by Maya Rosen of Harvard University, US, and colleagues.
A new study found that treatment-resistant epilepsy (TRE) is common in idiopathic autism. Early age at the onset of seizures and delayed global development were associated with a higher frequency of resistance to antiepileptic drugs (AEDs). Full findings appear online in Epilepsia, a journal published by Wiley-Blackwell on behalf of the International League Against Epilepsy (ILAE).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amy Susan Kranick, CNM 140 Hospital Dr, Suite 306, Bennington, VT 05201-5009 Ph: (802) 447-2677 | Amy Susan Kranick, CNM 140 Hospital Dr, Suite 306, Bennington, VT 05201-5009 Ph: (802) 447-2677 |
News Archive
Onyx Pharmaceuticals, Inc. today announced that it has reached the target enrollment in the ASPIRE trial, a Phase 3 international clinical trial evaluating carfilzomib in combination with lenalidomide (Revlimid) and low dose dexamethasone in patients with relapsed multiple myeloma.
Click4Care, a leading provider of care management software for payors, today announced the next-generation Utilization Management (UM) module for its industry leading software platform. By leveraging the UM solution's extensive configurability, payors and providers can achieve greater levels of productivity while improving clinical, administrative and financial performances.
There are a number of simple, practical steps that families can take-;including reducing passive screen time and news consumption, having a structured daily schedule and getting enough sleep-;that can promote resilience against mental health problems in youth during the COVID-19 pandemic, according to a new study published this week in the open-access journal PLOS ONE by Maya Rosen of Harvard University, US, and colleagues.
A new study found that treatment-resistant epilepsy (TRE) is common in idiopathic autism. Early age at the onset of seizures and delayed global development were associated with a higher frequency of resistance to antiepileptic drugs (AEDs). Full findings appear online in Epilepsia, a journal published by Wiley-Blackwell on behalf of the International League Against Epilepsy (ILAE).
› Verified 1 days ago
Betsy Lou Browning, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 532 Main St, Suite 1, Bennington, VT 05201 Phone: 802-447-2229 Fax: 802-440-9697 | |
Kim Marie Griffin, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 140 Hospital Drive, Suite 306, Bennington, VT 05201 Phone: 802-447-2677 Fax: 802-447-7710 |